Drug Shortage Report for AURO-TOPIRAMATE
Report ID | 207419 |
Drug Identification Number | 02345846 |
Brand name | AURO-TOPIRAMATE |
Common or Proper name | Auro-Topiramate 200mg |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TOPIRAMATE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-10-19 |
Actual start date | 2023-10-23 |
Estimated end date | 2024-05-15 |
Actual end date | 2024-05-13 |
Shortage status | Resolved |
Updated date | 2024-05-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-10-19 | French | Compare |
v1 | 2023-10-19 | English | Compare |